Rising Cases of Heartburn and GERD in 2022 Drive Global Antacid Market Growth, Affecting 784 Million People
Antacids, commonly used medications, help neutralize stomach acid to relieve symptoms like heartburn, acid reflux, and indigestion. Available over the counter (OTC) in liquid or chewable tablet forms, antacids are also effective in treating conditions like stomach ulcers and GERD by reducing excess stomach acid. Their widespread use worldwide highlights their effectiveness and safety. To ensure quality and efficacy, measuring buffering capacity and Antacid Neutralizing Capacity (ANC) is crucial, offering valuable insights for consumers. However, despite their benefits, care should be taken to avoid potential side effects or drug interactions, especially with increasing global usage.
Antacids are a staple in many households due to their accessibility and affordability. Consumers spend billions globally on these OTC treatments, which provide quick relief from acid-related conditions like GERD, upset stomachs, and hyperacidity. These medications work by neutralizing stomach acid and inhibiting pepsin, a digestive enzyme that can worsen acid-related symptoms.
Interestingly, some studies suggest that certain antacids are safe to use during pregnancy because their effects are localized rather than systemic. This makes them a preferred choice for managing acid reflux during pregnancy. Beyond their medicinal role, the antacid market has seen remarkable growth, driven by the increasing prevalence of digestive issues and the rising number of individuals seeking relief. The convenience of OTC availability has further fueled their global popularity and adoption.
The ease of purchasing antacids without a prescription has played a key role in expanding the global market. This accessibility not only meets the immediate needs of consumers but also supports the continued growth of the market.
For example, in May 2021, the Center for Chronic Disease and Control published a report predicting that the senior population will reach 94.7 million by 2060. GERD, which affects 20% or more of the elderly in outpatient settings, is becoming increasingly common as the population ages. With a growing elderly population, the demand for antacids is expected to rise significantly, driving market growth in the coming years.
The expanding need for effective and accessible digestive treatments ensures that the antacid market will continue to grow and evolve to meet consumer demand.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/antacids-market-size
Access exclusive insight now @ https://www.towardshealthcare.com/price/5079
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
C-Reactive Protein Testing Market: Growth and Trends The global C-reactive protein (CRP) testing market is valued at USD 5.58 billion… Read More
Insulin Delivery System Market Growth, Key Players and Trends The global insulin delivery system market is valued at US$ 17.77… Read More
AI in Precision Medicine Market Companies, Trends and Future Analysis The global market for Artificial Intelligence (AI) in precision medicine… Read More
IoT in Healthcare Market Key Insights and Projections The global IoT in healthcare market was valued at USD 36.2 billion… Read More
Stroke Diagnostics and Treatment Market Outlook The global stroke diagnostics and treatment market was valued at USD 34.45 billion in… Read More
Active Pharmaceutical Ingredients (APIs) Market Growth Outlook (2024 - 2032) The global APIs market is expected to grow from USD… Read More